Asthma and Obstructive Sleep Apnea (OSA)

NACompletedINTERVENTIONAL
Enrollment

744

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 7, 2012

Study Completion Date

June 25, 2012

Conditions
AsthmaObstructive Sleep Apnea
Interventions
OTHER

FDA-Approved Treatment

8 weeks of treatment with Continuous Positive Airway Pressure (CPAP)

Trial Locations (1)

53792

Univeristy of Wisconsin Hospital and Clinics, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT01026298 - Asthma and Obstructive Sleep Apnea (OSA) | Biotech Hunter | Biotech Hunter